• Explore /
  • Poster
  • / Neutrophil-to-lymphocyte ratio as a prognostic biomarker for overall survival in men with advanced prostate cancer treated with platinum chemotherapy.

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for overall survival in men with advanced prostate cancer treated with platinum chemotherapy.

Abstract Poster

Authors

Panagiotis Vlachostergios

Panagiotis J. Vlachostergios

Division of Hematology & Medical Oncology, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY

Panagiotis J. Vlachostergios , Aileen Lee , Charlene Thomas , Amy Hackett , Ana M. Molina , David M. Nanus , Himisha Beltran , Scott T. Tagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 266)

DOI

10.1200/JCO.2019.37.7_suppl.266

Abstract #

266

Poster Bd #

M1

Abstract Disclosures

Similar Posters

First Author: Konrad Stawiski

First Author: Inkeun Park

First Author: Jean H. Hoffman-Censits

First Author: Arnold I. Chin